Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D E Casey

Showing results (41-50 of 123) with videos related to

Pageof 13
Sort By:
The Journal of Clinical Psychiatry|April 1, 1985
Spontaneous and tardive dyskinesias: clinical and laboratory studiesD E Casey
The New England Journal of Medicine|May 20, 1993
Actual versus self-reported intake and exercise in obesityD E Casey
The New England Journal of Medicine|November 4, 1976
Tardive dyskinesia: are there subtypes?D E Casey
The American Journal of Psychiatry|August 1, 1975
Deanol in the treatment of tardive dyskinesiaD E Casey, D Denny
Psychopharmacology|September 15, 1999
Behavioral effects of ketamine, an NMDA glutamatergic antagonist, in non-human primatesY Shiigi, D E Casey
Behavioural Pharmacology|September 8, 2001
Effects of benztropine on ketamine-induced behaviors in Cebus monkeysY Shiigi, D E Casey
Psychopharmacology|January 1, 1987
Pargyline reduces/prevents neuroleptic-induced acute dystonia in monkeysR Heintz, D E Casey
Transactions of the American Neurological Association|January 1, 1979
Sulpiride and oxiperomide in tardive dyskinesiaD E Casey, J Gerlach
Psychopharmacology|March 1, 1996
New antipsychotics: preclinical and clinical researchJ Gerlach, D E Casey
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 1, 1990
Remoxipride, a new selective D2 antagonist, and haloperidol in cebus monkeysJ Gerlach, D E Casey
Pageof 13

Showing results (41-50 of 123) with videos related to

Sort By:
Pageof 13
The Journal of Clinical Psychiatry|April 1, 1985
Spontaneous and tardive dyskinesias: clinical and laboratory studiesD E Casey
The New England Journal of Medicine|May 20, 1993
Actual versus self-reported intake and exercise in obesityD E Casey
The New England Journal of Medicine|November 4, 1976
Tardive dyskinesia: are there subtypes?D E Casey
The American Journal of Psychiatry|August 1, 1975
Deanol in the treatment of tardive dyskinesiaD E Casey, D Denny
Psychopharmacology|September 15, 1999
Behavioral effects of ketamine, an NMDA glutamatergic antagonist, in non-human primatesY Shiigi, D E Casey
Behavioural Pharmacology|September 8, 2001
Effects of benztropine on ketamine-induced behaviors in Cebus monkeysY Shiigi, D E Casey
Psychopharmacology|January 1, 1987
Pargyline reduces/prevents neuroleptic-induced acute dystonia in monkeysR Heintz, D E Casey
Transactions of the American Neurological Association|January 1, 1979
Sulpiride and oxiperomide in tardive dyskinesiaD E Casey, J Gerlach
Psychopharmacology|March 1, 1996
New antipsychotics: preclinical and clinical researchJ Gerlach, D E Casey
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 1, 1990
Remoxipride, a new selective D2 antagonist, and haloperidol in cebus monkeysJ Gerlach, D E Casey
Pageof 13